NCT00352066View on ClinicalTrials.gov

Pharmacokinetics of Apricitabine and Tipranavir When Dosed Alone or Together

PHASE1CompletedINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2006

Conditions

HIV Infection

Interventions

DRUG

apricitabine

Trial Locations (1)

49007

Jasper Clinic Inc, Kalamazoo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Avexa

INDUSTRY

NCT00352066 - Pharmacokinetics of Apricitabine and Tipranavir When Dosed Alone or Together | Biotech Hunter | Biotech Hunter